Nanocrystals are already used in millions of devices, including televisions, laptops and displays, and are considered key ...
Nearly a year after the pilot survey was announced, fieldwork is yet to begin. As publishers question the survey framework, ...
For researchers on the hunt for the genetic roots of disease, the cost of deep whole-genome sequencing makes it challenging ...
It provides patients with a less painful and invasive screening option. Read more at straitstimes.com. Read more at ...
Bermuda remains on the fence about whether the island should become a full member of Caricom, survey findings suggest, but ...
Premier American Uranium Inc. (“PUR”, the “Company” or “Premier American Uranium”) (TSXV: PUR) (OTCQB: PAUIF) is pleased to ...
A new artificial intelligence tool may soon change how doctors understand breast cancer risk, offering faster answers and ...
National-scale initiative will profile ~21,000 plasma samples from 10,000 Alzheimer’s Disease and Related Dementias (ADRD) participants using Alamar Biosciences' NULISAseq™ Neuro 220 panel.
Researchers have combined machine learning with portable biosensors to accurately detect a dangerous cyanobacterial toxin ...
This article explores how biobanks, proteomics, and AI are enabling population-scale insights, earlier disease detection, and ...
Explore Agilent Technologies laboratory innovations, AI software, chromatography products, and scientific operations within ...
The excitement around psilocybin research for the treatment of depressive disorders has spurred momentum worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results